抗小鼠FcγRIV抗体9E9在体内也能阻断FcγRIII。 - Suppr

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

作者信息

Tipton Thomas R W, Mockridge C Ian, French Ruth R, Tutt Alison L, Cragg Mark S, Beers Stephen A

机构信息

Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.

出版信息

Blood. 2015 Dec 10;126(24):2643-5. doi: 10.1182/blood-2015-09-671339. Epub 2015 Oct 22.

DOI:10.1182/blood-2015-09-671339

PMID:26492935

Abstract

摘要

相似文献

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

Blood. 2015 Dec 10;126(24):2643-5. doi: 10.1182/blood-2015-09-671339. Epub 2015 Oct 22.

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

Blood. 2008 Aug 15;112(4):1205-13. doi: 10.1182/blood-2008-01-135160. Epub 2008 May 21.

Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

J Exp Med. 2006 Mar 20;203(3):743-53. doi: 10.1084/jem.20052283. Epub 2006 Mar 6.

B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

J Immunol. 2008 Mar 1;180(5):2863-75. doi: 10.4049/jimmunol.180.5.2863.

A case of mistaken identity: The MAR-1 antibody to mouse FcεRIα cross-reacts with FcγRI and FcγRIV.

J Allergy Clin Immunol. 2019 Apr;143(4):1643-1646.e6. doi: 10.1016/j.jaci.2018.11.045. Epub 2019 Jan 10.

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

Springer Semin Immunopathol. 2006 Dec;28(4):351-64. doi: 10.1007/s00281-006-0057-9. Epub 2006 Nov 8.

In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.

Eur J Immunol. 2010 Mar;40(3):780-6. doi: 10.1002/eji.200939613.

[Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy].

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):29-34. doi: 10.2177/jsci.32.29.

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

Leukemia. 2013 Jan;27(1):190-201. doi: 10.1038/leu.2012.150. Epub 2012 Jun 4.

Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation.

MAbs. 2016 Aug-Sep;8(6):1098-106. doi: 10.1080/19420862.2016.1189049. Epub 2016 May 24.

引用本文的文献

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.

Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf015.

The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment.

Front Pharmacol. 2024 Apr 16;15:1376955. doi: 10.3389/fphar.2024.1376955. eCollection 2024.

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects.

Signal Transduct Target Ther. 2023 Aug 18;8(1):306. doi: 10.1038/s41392-023-01521-5.

Immunoglobulin G subclasses confer protection against bloodstream dissemination through distinct mechanisms in mouse models.

Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220765120. doi: 10.1073/pnas.2220765120. Epub 2023 Mar 27.

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.

Cell Rep. 2022 Jul 19;40(3):111099. doi: 10.1016/j.celrep.2022.111099.

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering.

Commun Biol. 2022 Mar 14;5(1):229. doi: 10.1038/s42003-022-03182-6.

Differential and sequential immunomodulatory role of neutrophils and Ly6C inflammatory monocytes during antiviral antibody therapy.

Emerg Microbes Infect. 2021 Dec;10(1):964-981. doi: 10.1080/22221751.2021.1913068.

Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.

Blood. 2020 Oct 29;136(18):2065-2079. doi: 10.1182/blood.2020005571.

Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.

Cancer Cell. 2018 Jun 11;33(6):1033-1047.e5. doi: 10.1016/j.ccell.2018.05.005.

Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.

Cancer Cell. 2017 Dec 11;32(6):777-791.e6. doi: 10.1016/j.ccell.2017.11.001. Epub 2017 Nov 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

作者信息

Tipton Thomas R W, Mockridge C Ian, French Ruth R, Tutt Alison L, Cragg Mark S, Beers Stephen A

机构信息

Antibody and Vaccine Group, Cancer Sciences Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom.

出版信息

Blood. 2015 Dec 10;126(24):2643-5. doi: 10.1182/blood-2015-09-671339. Epub 2015 Oct 22.

DOI:10.1182/blood-2015-09-671339

PMID:26492935

Abstract

摘要

相似文献

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

Blood. 2015 Dec 10;126(24):2643-5. doi: 10.1182/blood-2015-09-671339. Epub 2015 Oct 22.

Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcgammaRI, FcgammaRIII, and FcgammaRIV.

Blood. 2008 Aug 15;112(4):1205-13. doi: 10.1182/blood-2008-01-135160. Epub 2008 May 21.

Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

J Exp Med. 2006 Mar 20;203(3):743-53. doi: 10.1084/jem.20052283. Epub 2006 Mar 6.

B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.

J Immunol. 2008 Mar 1;180(5):2863-75. doi: 10.4049/jimmunol.180.5.2863.

A case of mistaken identity: The MAR-1 antibody to mouse FcεRIα cross-reacts with FcγRI and FcγRIV.

J Allergy Clin Immunol. 2019 Apr;143(4):1643-1646.e6. doi: 10.1016/j.jaci.2018.11.045. Epub 2019 Jan 10.

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.

Springer Semin Immunopathol. 2006 Dec;28(4):351-64. doi: 10.1007/s00281-006-0057-9. Epub 2006 Nov 8.

In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.

Eur J Immunol. 2010 Mar;40(3):780-6. doi: 10.1002/eji.200939613.

[Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy].

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):29-34. doi: 10.2177/jsci.32.29.

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

Leukemia. 2013 Jan;27(1):190-201. doi: 10.1038/leu.2012.150. Epub 2012 Jun 4.

Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation.

MAbs. 2016 Aug-Sep;8(6):1098-106. doi: 10.1080/19420862.2016.1189049. Epub 2016 May 24.

引用本文的文献

FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.

Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf015.

The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment.

Front Pharmacol. 2024 Apr 16;15:1376955. doi: 10.3389/fphar.2024.1376955. eCollection 2024.

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects.

Signal Transduct Target Ther. 2023 Aug 18;8(1):306. doi: 10.1038/s41392-023-01521-5.

Immunoglobulin G subclasses confer protection against bloodstream dissemination through distinct mechanisms in mouse models.

Proc Natl Acad Sci U S A. 2023 Apr 4;120(14):e2220765120. doi: 10.1073/pnas.2220765120. Epub 2023 Mar 27.

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.

Cell Rep. 2022 Jul 19;40(3):111099. doi: 10.1016/j.celrep.2022.111099.

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering.

Commun Biol. 2022 Mar 14;5(1):229. doi: 10.1038/s42003-022-03182-6.

Differential and sequential immunomodulatory role of neutrophils and Ly6C inflammatory monocytes during antiviral antibody therapy.

Emerg Microbes Infect. 2021 Dec;10(1):964-981. doi: 10.1080/22221751.2021.1913068.

Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.

Blood. 2020 Oct 29;136(18):2065-2079. doi: 10.1182/blood.2020005571.

Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens.

Cancer Cell. 2018 Jun 11;33(6):1033-1047.e5. doi: 10.1016/j.ccell.2018.05.005.

Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.

Cancer Cell. 2017 Dec 11;32(6):777-791.e6. doi: 10.1016/j.ccell.2017.11.001. Epub 2017 Nov 30.

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivo.

作者信息

机构信息

出版信息

相似文献

引用本文的文献